Published: November 25, 1998Received: -Available on J-STAGE: June 28, 2010Accepted: -
Advance online publication: -
Revised: -
Correction information
Date of correction: June 28, 2010Reason for correction: -Correction: KEYWORDDetails: [in Japanese]
Date of correction: June 28, 2010Reason for correction: -Correction: CITATIONDetails: Wrong : E E E E E E E E E
Right : 1)Creech O, Krementz ET, Ryan RF. Winblad JN,: Chemotherapy of cancer; regional per fusion utilizing an extracorporeal circuit. Ann Surg, 148; 616-632, 1959. 2)Wanebo HJ, Chung MA, Levy AI, etal.: Preoperative therapy for advanced pelvic malig nancy by isolated pelvic perfusion with the balloo n-occlusion technique.Ann Surg Oncol, 3(3);295-303, 1996. 3)DeCian F, V Bachi, Mondini G, et al.: Pelvic perfusion in the adjuvant therapy of locally advanced rectal cancer. Feasibility trial and ini tial clinical experience. Dis Colon Rectum,37(2 Suppl): S106-114, 1994. 4)Kocaoglu HM, A Yerdel, Cetin R, et al.: Treatment of nonresectable pelvic malignancies by isolated pelvic perfusion. A preliminary study. Eur J Surg Oncol, 21(5); 535-540, 1995. 5)Turk PS, JF Belliveau, Darnowski JW, et al.: Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg,128(5);533-539,1993. 6)Wile AG, EA Stemmer, Andrews PA, et al.:P harmacokinetics of5-fluorouracil during hyperthermic pelvic isolation-perfusion. J Clin Oncol, 3(6);849-852, 1985. 7)Dewey WC, Hopwood LE, Sapareto SA, et al.: Cellular responses to combinations of hyper thermia and radiation. Radiology, 123; 463-474, 1977. 8)Hahn GM, Li GC: Interactions of hyperther mia and drugs: treatments and probes. Natl Cancer Inst Monogr, 61; 317-323, 1982. 9)Leeper DB: Molecular and cellular mecha nisms of hyperthermia alone or combined with other motdalities. Leeper DB.(ed by Overgaard J.); Hyperthermia Oncology. London, Taylor and Francis. 1985. P. 9-40.